The placebo effect and endogenous opioids Dr de Craen and colleagues (October 1999 JRSM, pp. 511± 515) discuss the possible role of endogenous opioids in the placebo effect. I would like to elaborate on this issue.
An innovative study was conducted by Levine et al. about 20 years ago 1 . They hypothesized that endogenous endorphin might play a role in mediating placebo response. To test this hypothesis they studied the effect of naloxone, an opioid antagonist, on postoperative pain after extraction of impacted molars. Under double-blind, randomized conditions, patients received either naloxone or placebo several hours after surgery. Patients who were given naloxone reported signi®cantly greater pain than those who received placebo. Patients given placebo as their ®rst drug were divided into placebo responders, whose pain was reduced or unchanged, and non-responders, whose pain increased. Placebo non-responders had nearly the same postoperative pain levels as those who received naloxone. Naloxone given as a second drug did not increase pain levels in non-responders but did increase pain levels of placebo responders. Levine et al. concluded that endorphin release mediated placebo analgesia. The observations that people who are placebo responders get considerably more relief from pain with narcotic analgesics than do non-responders 2,3 and that placebo may partly reverse withdrawal symptoms in patients with opioid dependence 4 also support the theory that endogenous opioids are involved in the placebo effect. In 1997, I suggested that the interaction between the endogenous opioid system and different neurotransmitter systems in the brain mediates the placebo effect on mood and behaviour of healthy and sick people 5 . Further research is necessary to elucidate mechanisms of placebo effects.
The placebo effect is an impressive example of transformation of psychological effects into biological processes. The importance of the placebo effect should not be underestimated. The ®ndings of Dr Bradding and Dr Cookson (December 1999 JRSM, pp. 632±634) show that the current situation is far from satisfactory, though I suspect it is much superior to that in the United States, where there is no teaching of cardiac auscultation in three-quarters of the internal medicine programmes 1 . However, Bradding and Cookson did not assess the teaching of the clinical signs of acute respiratory distress 2 ; which in my opinion are of vital importance in intensive care when a patient is under consideration for mechanical ventilation, or is being weaned from the machine. Unfortunately the quantitative relationships between clinical signs and the underlying mechanical and physiological changes in acute respiratory failure are still largely unexplored, though recently intensivists in the USA have accepted the importance of clinical assessment in this context and lessened the strong emphasis on`the scienti®c approach', in particular blood gas analysis. Sir William Osler's (1849±1919) aphorism,`Don't touch the patient, state ®rst what you see!', should surely continue to be taught even in the 21st century, whatever scienti®c advances are achieved.
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